Triage Procedures for Critical Care Resource Allocation During Scarcity.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 08 2023
Historique:
medline: 31 8 2023
pubmed: 29 8 2023
entrez: 29 8 2023
Statut: epublish

Résumé

During the COVID-19 pandemic, many US states issued or revised pandemic preparedness plans guiding allocation of critical care resources during crises. State plans vary in the factors used to triage patients and have faced criticism from advocacy groups due to the potential for discrimination. To analyze the role of comorbidities and long-term prognosis in state triage procedures. This cross-sectional study used data gathered from parallel internet searches for state-endorsed pandemic preparedness plans for the 50 US states, District of Columbia, and Puerto Rico (hereafter referred to as states), which were conducted between November 25, 2021, and June 16, 2023. Plans available on June 16, 2023, that provided step-by-step instructions for triaging critically ill patients were categorized for use of comorbidities and prognostication. Prevalence and contents of lists of comorbidities and their stated function in triage and instructions to predict duration of postdischarge survival. Overall, 32 state-promulgated pandemic preparedness plans included triage procedures specific enough to guide triage in clinical practice. Twenty of these (63%) included lists of comorbidities that excluded (11 of 20 [55%]) or deprioritized (8 of 20 [40%]) patients during triage; one state's list was formulated to resolve ties between patients with equal triage scores. Most states with triage procedures (21 of 32 [66%]) considered predicted survival beyond hospital discharge. These states proposed different prognostic time horizons; 15 of 21 (71%) were numeric (ranging from 6 months to 5 years after hospital discharge), with the remaining 6 (29%) using descriptive terms, such as long-term. In this cross-sectional study of state-promulgated critical care triage policies, most plans restricted access to scarce critical care resources for patients with listed comorbidities and/or for patients with less-than-average expected postdischarge survival. This analysis raises concerns about access to care during a public health crisis for populations with high burdens of chronic illness, such as individuals with disabilities and minoritized racial and ethnic groups.

Identifiants

pubmed: 37642967
pii: 2808873
doi: 10.1001/jamanetworkopen.2023.29688
pmc: PMC10466166
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2329688

Subventions

Organisme : NIA NIH HHS
ID : R03 AG073987
Pays : United States
Organisme : NIA NIH HHS
ID : K24 AG068312
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Chest. 2022 Feb;161(2):504-513
pubmed: 34506791
Chest. 2020 Oct;158(4):1332-1334
pubmed: 32450243
Hastings Cent Rep. 2021 Sep;51(5):18-29
pubmed: 34529846
Chest. 2022 Feb;161(2):e136
pubmed: 35131074
J Racial Ethn Health Disparities. 2021 Aug;8(4):824-836
pubmed: 32789816
JAMA. 2012 Jan 11;307(2):182-92
pubmed: 22235089
Bioethics. 2022 Sep;36(7):802-808
pubmed: 35533287
N Engl J Med. 2013 Jun 27;368(26):2448-50
pubmed: 23802514
BMC Fam Pract. 2015 Aug 27;16:110
pubmed: 26310664
PLoS One. 2016 Aug 25;11(8):e0161407
pubmed: 27560380
Clin Oncol (R Coll Radiol). 2001;13(3):209-18
pubmed: 11527298
JAMA. 2021 Apr 13;325(14):1469-1470
pubmed: 33595630
Disabil Health J. 2011 Apr;4(2):59-67
pubmed: 21419369
Rehabil Psychol. 2020 May;65(2):101-112
pubmed: 32105109
Prev Chronic Dis. 2020 Sep 17;17:E106
pubmed: 32945769
JAMA Netw Open. 2021 Jun 1;4(6):e2113891
pubmed: 34143190
J Health Polit Policy Law. 2021 Oct 1;46(5):831-860
pubmed: 33769474
Arch Intern Med. 2011 Oct 24;171(19):1721-6
pubmed: 21788535
Prev Chronic Dis. 2014 Jan 30;11:130251
pubmed: 24480632
JAMA Netw Open. 2020 Jun 1;3(6):e2012606
pubmed: 32558916
BMJ. 2003 Jul 26;327(7408):195-8
pubmed: 12881260
PLoS One. 2021 Sep 17;16(9):e0257608
pubmed: 34535009
Health Aff (Millwood). 2021 Feb;40(2):297-306
pubmed: 33523739
J Palliat Care. 2007 Summer;23(2):93-112
pubmed: 17853845
JAMA Health Forum. 2022 Jan 4;3(1):e214799
pubmed: 36218861
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
BMJ. 2000 Feb 19;320(7233):469-72
pubmed: 10678857
PLoS One. 2019 Jun 17;14(6):e0218462
pubmed: 31206556
Am J Respir Crit Care Med. 2021 Jul 15;204(2):178-186
pubmed: 33751910
Alzheimers Dement. 2019 Jan;15(1):17-24
pubmed: 30243772
Prev Chronic Dis. 2017 Oct 19;14:E101
pubmed: 29049018

Auteurs

Jackson S Ennis (JS)

Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota.

Kirsten A Riggan (KA)

Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota.

Nicholas V Nguyen (NV)

Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota.

Daniel B Kramer (DB)

Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Harvard Medical School Center for Bioethics, Boston, Massachusetts.

Alexander K Smith (AK)

Department of Medicine, Division of Geriatrics, University of California, San Francisco.
San Francisco Veterans Affairs Medical Center, San Francisco, California.

Daniel P Sulmasy (DP)

Departments of Medicine and Philosophy, Georgetown University, Washington, DC.
Kennedy Institute of Ethics, Georgetown University, Washington, DC.

Jon C Tilburt (JC)

Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota.
Division of General Internal Medicine, Mayo Clinic, Scottsdale, Arizona.

Susan M Wolf (SM)

University of Minnesota Medical School, Minneapolis.
University of Minnesota Law School, Minneapolis.

Erin S DeMartino (ES)

Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota.
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH